PODD
Ticker
Insulet Corp
Company
Devices
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
46.8%57.0%38.8%16.9%16.9%12.3%13.2%26.4%21.6%30.9%22.5%21.5%18.8%30.0%22.1% 27.1%
Revenue Growth QoQ
Gross Margin
27.7%45.1%43.8%43.7%45.5%49.6%45.7%57.5%59.8%65.7%65.1%64.4%68.4%61.7%68.3%69.8% 71.5%
EBITDA Margin
-82.0%-34.6%-22.3%-11.8%-7.0%-0.0%-13.9%0.9%1.4%7.6%10.6%11.8%16.7%7.7%17.3%18.8% 20.8%
Operating Margin
-89.9%-39.8%-27.9%-17.0%-11.8%-4.3%-18.7%-2.9%-1.6%4.9%6.8%5.7%11.5%2.9%13.0%14.9% 17.3%
Profit Margin
-109.6%-63.1%-30.1%-24.5%-18.2%-17.8%-22.7%-7.9%-5.8%0.6%1.6%0.8%1.5%0.4%12.2%20.2% 9.8%
FCF / EBITDA
96.9%125.7%107.7%160.6%22.8%3467.6%51.6%-198.3%-557.0%-293.7%-93.1%-77.2%-104.0%-38.0%12.5%76.0% 77.7%